文献速递鼻科

苦味受体表型对慢性鼻窦炎临床表现的影响

Impact of bitter taste receptor phenotype upon clinical presentation in chronic rhinosinusitis.
PubMed 文献 · Int Forum Allergy Rhinol · 2018-07-04

该研究前瞻性评估成人慢性鼻窦炎(CRS)患者对苯硫脲(PTC)的味觉敏感度,分为非尝味者、尝味者和超级尝味者。PTC尝味能力可能作为白人无鼻息肉CRS患者疾病严重程度的便捷标志物。

要点

  • 非尝味者更常见于白人、无鼻息肉、无哮喘的CRS患者。
  • PTC尝味能力与生活质量及嗅觉、味觉评分无显著关联。
  • PTC尝味能力可能提供其他主客观嗅觉味觉测量未获得的信息。

核心结论

  • 口服PTC感知能力可能作为白人无鼻息肉CRS患者疾病严重程度的便捷标志物,并随区域人群而异。

主要发现

  • 非尝味者更可能为非西班牙裔(p=0.018)、白人(p=0.027)、无鼻息肉(p=0.004)和无哮喘(p=0.019)。
  • 其他人口学、生活质量、主观或客观嗅觉和味觉评分无统计学差异。

关键数值与推荐

  • 非尝味者与非西班牙裔相关(p=0.018),与白人相关(p=0.027),与无鼻息肉相关(p=0.004),与无哮喘相关(p=0.019)。

临床怎么用

  • 口服PTC尝味能力可能作为白人无鼻息肉CRS患者疾病严重程度的便捷标志物。
  • PTC尝味能力提供其他主观或客观嗅觉味觉测量未获得的信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Genetic variation of the bitter taste receptor T2R38 has been associated with recalcitrant chronic rhinosinusitis (CRS). Specific T2R38 polymorphisms, correlating with bitter taste sensitivity to phenylthiocarbamide (PTC), have been identified as an independent risk factor for surgical intervention in CRS patients without polyps; however, the exact role of PTC tasting ability in clinical practice remains unknown. In this investigation we characterize PTC taste sensitivity in a tertiary care rhinology practice with pertinent clinical measures of disease and quality of life (QOL). METHODS: Adult CRS patients were prospectively assessed for their ability to taste PTC and categorized as nontasters, tasters, or supertasters. Objective taste was assessed with strips for bitter, sweet, sour, and salty, whereas olfactory testing was measured with Sniffin' Sticks. Correlation was performed between PTC tasting ability and patient demographics, endoscopy scores, validated QOL surveys, and both subjective and objective measures of taste and olfaction. RESULTS: Sixty-seven patients were enrolled. Fifty-two percent were identified as nontasters, 34% as tasters, and 13% as supertasters. Nontasters were more likely to be non-Hispanic (p = 0.018), white (p = 0.027), without nasal polyposis (p = 0.004), and nonasthmatics (p = 0.019). There were no other statistical differences in patients' demographics, QOL measures, and subjective or objective olfactory and taste scores when compared with patients' oral PTC-sensing ability. CONCLUSION: Oral PTC-sensing ability may serve as a convenient marker of increased disease severity in white CRS patients without polyps and vary among regional populations. PTC tasting ability appears to provide unique phenotypic information not obtained using other subjective or objective measures of smell and taste.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Rowan NR, Soler ZM, Othieno F, et al. Impact of bitter taste receptor phenotype upon clinical presentation in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2018. PMID: 29972727. doi:10.1002/alr.22138

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。